The Challenge
As cancer treatments become more effective, the population of cancer survivors continues to grow, with over 18 million in the United States alone and projected to reach 26 million by 2040. While surviving cancer is a tremendous achievement, many survivors face significant long-term effects from both the disease and its treatments: cardiovascular complications, secondary malignancies, cognitive impairment, psychological distress, chronic pain, fatigue, infertility, and other debilitating conditions that can persist for years or even decades.
Current approaches to survivorship care face substantial challenges: limited ability to predict which patients will develop specific long-term effects, reactive rather than preventive management, poor coordination between oncology and primary care, inadequate surveillance protocols, and insufficient personalization of survivorship care plans. These gaps result in preventable suffering, reduced quality of life, and sometimes shortened survival for many cancer survivors.
Our Approach
We aim to apply advanced artificial intelligence to transform the prediction, prevention, and management of long-term effects in cancer survivors. Our multifaceted approach includes:
- Developing predictive models that can identify patients at highest risk for specific long-term effects based on their treatment exposures, medical history, genomic factors, and other characteristics
- Creating personalized surveillance and intervention recommendation systems that optimize the timing and intensity of follow-up based on individual risk profiles
- Building decision support tools that help physicians select initial cancer treatments that balance immediate efficacy with long-term quality of life considerations
- Designing AI-powered symptom monitoring platforms that can detect early signs of long-term effects before they become severe
- Developing comprehensive survivorship care coordination systems that facilitate seamless collaboration between oncology, primary care, and specialty services
Risk Prediction
AI models that identify which survivors are at highest risk for specific long-term effects, enabling targeted prevention and surveillance strategies.
Personalized Surveillance
Systems that optimize follow-up schedules and testing based on individual risk profiles, maximizing early detection while minimizing patient burden.
Treatment Optimization
Tools that help oncologists select initial treatments that balance immediate efficacy with potential long-term impacts on quality of life.
Care Coordination
AI-powered platforms that facilitate communication and coordination between the multiple providers involved in survivorship care.
Potential Research Projects
Comprehensive Cardiotoxicity Prediction
We could develop AI models that predict the risk of cardiovascular complications—including heart failure, arrhythmias, coronary artery disease, and vascular dysfunction—from cancer therapies. These models would integrate multiple data sources including treatment details (drugs, doses, schedules), imaging studies (echocardiograms, cardiac MRI), biomarkers, genetic information, and pre-existing risk factors. By providing personalized risk assessments, the system could guide cardioprotective strategies, surveillance protocols, and early interventions for high-risk patients.
Dynamic Survivorship Care Planning
This project would create an AI system that generates and continuously updates personalized survivorship care plans. Unlike static plans commonly used today, these would adapt dynamically based on emerging symptoms, test results, treatment responses, and evolving risk profiles. The system would provide specific recommendations for screening tests, interventions, lifestyle modifications, and specialist referrals tailored to each survivor's unique health status, treatment history, and risk factors.
Treatment Decision Support for Survivorship
We aim to create decision support tools that help oncologists balance immediate treatment goals with long-term quality of life considerations. These tools would simulate the potential impacts of different treatment regimens on both immediate cancer control and long-term survivorship outcomes, allowing physicians and patients to make more informed decisions. For example, the system might identify when a slightly less aggressive treatment approach could maintain excellent cancer control while substantially reducing long-term toxicity risks.
Cognitive Function Monitoring and Rehabilitation
This project would develop AI tools for monitoring, predicting, and addressing cancer-related cognitive impairment ("chemo brain"). The system would combine periodic cognitive assessments with digital phenotyping (patterns of smartphone use, speech analysis, etc.) to detect subtle cognitive changes early. It would then provide personalized cognitive rehabilitation recommendations, potentially including cognitive training exercises, compensatory strategies, and lifestyle interventions tailored to the specific cognitive domains affected in each survivor.
Technical Innovations
Our survivorship research would leverage several cutting-edge technical approaches:
- Time-to-event modeling: Advanced approaches for predicting when specific long-term effects might emerge, enabling timely interventions
- Transfer learning: Techniques to leverage insights across different treatment modalities and cancer types for better prediction
- Multi-objective optimization: Methods to balance multiple competing goals in treatment selection, including survival and quality of life
- Natural language processing: Approaches to extract meaningful insights from clinical notes and patient narratives
- Reinforcement learning: Techniques to optimize long-term health outcomes through sequential decision-making
- Digital phenotyping: Methods to passively monitor patient function through everyday device interactions
Long-Term Effects Focus
Our research would address several key categories of long-term effects:
Cardiovascular Effects
Predicting and managing heart failure, arrhythmias, coronary disease, and vascular dysfunction associated with chemotherapy and radiation.
Secondary Malignancies
Identifying patients at highest risk for treatment-induced cancers and developing optimal screening and prevention strategies.
Neurocognitive Effects
Addressing cognitive impairment, neuropathy, and other neurological sequelae of cancer treatments through early detection and intervention.
Survivorship Domains
AI approaches could address key aspects of comprehensive survivorship care:
Surveillance & Screening
Optimizing protocols for monitoring cancer recurrence, secondary malignancies, and treatment-related toxicities based on personalized risk profiles.
Symptom Management
Developing personalized approaches to address persistent symptoms like fatigue, pain, cognitive changes, and psychological distress.
Psychosocial Support
Creating tools to identify survivors needing additional support for anxiety, depression, post-traumatic stress, and social reintegration.
Lifestyle Optimization
Building personalized recommendation systems for nutrition, physical activity, sleep, and other behaviors that can improve survivorship outcomes.
Cancer Type Focus
Our research would address survivorship in specific cancer types with unique long-term challenges:
- Breast cancer: Addressing cardiotoxicity, bone health, menopausal symptoms, and cognitive effects in a large survivor population
- Childhood cancers: Managing developmental impacts, growth effects, fertility concerns, and very long-term risks over decades
- Head and neck cancers: Addressing unique challenges related to speech, swallowing, nutrition, and social functioning
- Hematologic malignancies: Managing immune dysfunction, graft-versus-host disease, and other complex effects of intensive treatments
- Prostate cancer: Balancing long-term hormone therapy effects on cardiovascular health, cognition, bone health, and metabolic function
- Colorectal cancer: Addressing bowel function, neuropathy, nutritional challenges, and ostomy management in survivors
Future Directions
As our research progresses, we plan to explore several exciting directions:
- Developing integrated digital platforms that empower survivors to actively manage their own long-term health
- Creating AI approaches that can predict how emerging cancer treatments might impact long-term survivorship outcomes
- Building comprehensive models of aging in cancer survivors to distinguish treatment effects from normal aging processes
- Exploring how AI can help address financial toxicity and return-to-work challenges for cancer survivors
- Developing approaches to optimize quality of life across the entire cancer continuum from diagnosis through long-term survivorship
Collaborations and Partnerships
We would be interested in exploring partnerships with:
Survivorship Programs
To implement and evaluate AI-powered survivorship care approaches in real-world clinical settings
Survivor Advocacy Groups
To ensure our research priorities and approaches reflect the needs and preferences of cancer survivors
Primary Care Networks
To develop approaches that better integrate survivorship care with general medical care over the long term
Research Background
This research area contributes to the growing body of knowledge in AI-powered cancer research. We're currently developing foundational work in this space.
Related Research Areas
Stay Updated
Subscribe to receive updates on our latest research findings and breakthroughs.